Yuhsin Kuo
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)United States Military Academy(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Pharmacogenetics and Drug Metabolism, Ion channel regulation and function, Drug Transport and Resistance Mechanisms, Receptor Mechanisms and Signaling
Most-Cited Works
- → Design, Synthesis, and Evaluation of a Novel 4-Aminomethyl-4-fluoropiperidine as a T-Type Ca2+Channel Antagonist(2008)131 cited
- → Pharmacokinetics of Dietary Phenethyl Isothiocyanate in Rats(2005)99 cited
- → Discovery of 1,4-Substituted Piperidines as Potent and Selective Inhibitors of T-Type Calcium Channels(2008)93 cited
- → In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters(2013)57 cited
- → 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts(2010)40 cited
- → Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel Antagonists(2010)38 cited
- → In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies(2006)33 cited
- → Pyridyl amides as potent inhibitors of T-type calcium channels(2011)31 cited
- → Bioactivation of 2,3-Diaminopyridine-Containing Bradykinin B1 Receptor Antagonists: Irreversible Binding to Liver Microsomal Proteins and Formation of Glutathione Conjugates(2005)29 cited
- → Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonists(2010)26 cited